{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:57:13Z","timestamp":1760705833243,"version":"3.40.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Patients who had mechanical heart valves and an international normalized ratio (INR) of &gt;5.0 should be managed by temporary cessation of vitamin K antagonist. This study aimed to investigate the safety of low-dose vitamin K1 in patients with mechanical heart valves who have supratherapeutic INR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>CINAHL, Cochran Library, Clinical trial.gov, OpenGrey, PubMed, ScienceDirect, and Scopus were systematically searched from the inception up to October 2021 without language restriction. Studies comparing the safety of low-dose vitamin K1 treatment in patients with placebo or other anticoagulant reversal agents were included. We used a random-effect model for the meta-analysis. Publication bias was determined by a funnel plot with subsequent Begg\u2019s test and Egger\u2019s test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From 7529 retrieved studies, 3 randomized control trials were included in the meta-analysis. Pooled data demonstrated that low-dose vitamin K was not associated with thromboembolism rate (risk ratio [RR] = 0.94; 95% CI: 0.19\u20134.55) major bleeding rate (RR = 0.58; 95% CI: 0.07\u20134.82), and minor bleeding rate (RR = 0.60; 95% CI: 0.07\u20135.09). Subgroup and sensitivity analysis demonstrated the nonsignificant effect of low-dose vitamin K on the risk of thromboembolism. Publication bias was not apparent, according to Begg\u2019s test and Egger\u2019s test (<jats:italic toggle=\"yes\">P<\/jats:italic> = .090 and 0.134, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The current evidence does not support the role of low-dose vitamin K as a trigger of thromboembolism in supratherapeutic INR patients with mechanical heart valves. Nevertheless, more well-designed studies with larger sample sizes are required to justify this research question.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030388","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T19:43:44Z","timestamp":1662752624000},"page":"e30388","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Safety of Vitamin K in mechanical heart valve patients with supratherapeutic INR: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"101","author":[{"given":"Bannawich","family":"Sapapsap","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chansinee","family":"Srisawat","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical care, Department of Pharmacy, Banphaeo General Hospital, Samut Sakhon, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornsinee","family":"Suthumpoung","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical care, Department of Pharmacy, Fort Khuncheangthammikkarat Hospital, Phayao, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onjira","family":"luengrungkiat","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Care, Department of Pharmacy, Wichaivej International Omnoi Hospital, Samutsakhon, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattawut","family":"Leelakanok","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasak","family":"Saokaew","sequence":"additional","affiliation":[{"name":"Division of Social and Administration Pharmacy, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Unit of Excellence on Clinical Outcomes Research and IntegratioN (UNICORN), School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Unit of Excellence on Herbal Medicine, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Biofunctional Molecule Exploratory Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor Darul Ehsan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1268-2665","authenticated-orcid":false,"given":"Sukrit","family":"Kanchanasurakit","sequence":"additional","affiliation":[{"name":"Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Unit of Excellence on Clinical Outcomes Research and IntegratioN (UNICORN), School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Unit of Excellence on Herbal Medicine, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Division of Clinical Pharmacy, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"},{"name":"Division of Pharmaceutical care, Department of Pharmacy, Phrae Hospital, Phrae, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends.","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIR.0000000000000932","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"Suppl 3","key":"R3-20250504","doi-asserted-by":"crossref","first-page":"204s","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"issue":"Suppl 2","key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2017-03-742304","article-title":"How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy.","volume":"129","author":"Schulman","year":"2017","journal-title":"Blood"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(00)03125-1","article-title":"Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.","volume":"356","author":"Crowther","year":"2000","journal-title":"Lancet"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/archinte.158.5.528","article-title":"Evaluation of excessive anticoagulation in a group model health maintenance organization.","volume":"158","author":"Lousberg","year":"1998","journal-title":"Arch Intern Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jacc.2005.05.022","article-title":"A randomized trial comparing 1\u2009mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.","volume":"46","author":"Ageno","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amjcard.2005.08.062","article-title":"Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.","volume":"97","author":"Yiu","year":"2006","journal-title":"Am J Cardiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00228-021-03127-8","article-title":"Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.","volume":"77","author":"Zhang","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jnci\/81.2.107","article-title":"Publication bias and dissemination of clinical research.","volume":"81","author":"Begg","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","article-title":"Bias in location and selection of studies.","volume":"316","author":"Egger","year":"1998","journal-title":"Bmj"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2288-14-132","article-title":"A modified regression method to test publication bias in meta-analyses with binary outcomes.","volume":"14","author":"Jin","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","article-title":"Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data.","volume":"9","author":"Wallace","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/bloodadvances.2018025163","article-title":"Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis.","volume":"3","author":"Khatib","year":"2019","journal-title":"Blood Adv"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4065\/76.3.260","article-title":"Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.","volume":"76","author":"Shields","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TA.0000000000000480","article-title":"Does resuscitation with plasma increase the risk of venous thromboembolism?","volume":"78","author":"Zander","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"Suppl 1","key":"R25-20250504","first-page":"65S","article-title":"Adverse effects of plasma transfusion.","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfusion"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/trf.13191","article-title":"Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal.","volume":"55","author":"Refaai","year":"2015","journal-title":"Transfusion"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.ejcn.1602037","article-title":"Ethnic differences in osteocalcin gamma-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype.","volume":"59","author":"Beavan","year":"2005","journal-title":"Eur J Clin Nutr"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3945\/jn.111.154278","article-title":"Circulating phylloquinone concentrations of adults in the United States differ according to race and ethnicity.","volume":"142","author":"Shea","year":"2012","journal-title":"J Nutr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:32:00Z","timestamp":1746336720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":26,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030388","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,9,9]]}}}